The solution-phase synthesis of a muramyl dipeptide（MDP） analogue of N~α-[4-chlorocinnamoyl-L-alanyl-D-isoglutaminyl]-L-lysine （MDA,2） is reported that possesses the features of easy feasibility,safety and low co...The solution-phase synthesis of a muramyl dipeptide（MDP） analogue of N~α-[4-chlorocinnamoyl-L-alanyl-D-isoglutaminyl]-L-lysine （MDA,2） is reported that possesses the features of easy feasibility,safety and low cost in large scale of synthesis.展开更多
基金supported financially by the National Natural Science Foundation of China(No.90713045)
文摘The solution-phase synthesis of a muramyl dipeptide（MDP） analogue of N~α-[4-chlorocinnamoyl-L-alanyl-D-isoglutaminyl]-L-lysine （MDA,2） is reported that possesses the features of easy feasibility,safety and low cost in large scale of synthesis.
